The cytochrome bc
Antifungal Agents
/ pharmacology
Antimalarials
/ therapeutic use
Electron Transport Complex III
/ antagonists & inhibitors
Fungal Proteins
/ antagonists & inhibitors
Fungi
/ enzymology
Humans
Malaria, Falciparum
/ drug therapy
Plant Diseases
/ microbiology
Plasmodium falciparum
/ enzymology
Protozoan Proteins
/ antagonists & inhibitors
G143A
QoI/QiI
cytochrome bc1
electron transport
fungicide
malaria
resistance
Journal
FEBS letters
ISSN: 1873-3468
Titre abrégé: FEBS Lett
Pays: England
ID NLM: 0155157
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
10
04
2020
revised:
31
05
2020
accepted:
10
06
2020
pubmed:
24
6
2020
medline:
12
5
2021
entrez:
24
6
2020
Statut:
ppublish
Résumé
The cytochrome bc
Identifiants
pubmed: 32573760
doi: 10.1002/1873-3468.13868
doi:
Substances chimiques
Antifungal Agents
0
Antimalarials
0
Fungal Proteins
0
Protozoan Proteins
0
Electron Transport Complex III
EC 7.1.1.8
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2935-2952Subventions
Organisme : Medical Research Council
ID : MC_PC_17167
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L000644/1
Pays : United Kingdom
Informations de copyright
© 2020 Federation of European Biochemical Societies.
Références
Kessl JJ, Meshnick SR and Trumpower BL (2007) Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi. Trends Parasitol 23, 494-501.
Barton V, Fisher N, Biagini GA, Ward SA and O'Neill PM (2010) Inhibiting Plasmodium cytochrome bc1: a complex issue. Curr Opin Chem Biol 14, 440-446.
Biagini GA, Fisher N, Shone AE, Mubaraki MA, Srivastava A, Hill A, Antoine T, Warman AJ, Davies J, Pidathala C et al. (2012) Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria. Proc Natl Acad Sci USA 109, 8298-8303.
Birth D, Kao WC and Hunte C (2014) Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action. Nature Commun 5, 4029.
Capper MJ, O'Neill PM, Fisher N, Strange RW, Moss D, Ward SA, Berry NG, Lawrenson AS, Hasnain SS, Biagini GA et al. (2015) Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1. Proc Natl Acad Sci USA 112, 755-760.
Fehr M, Wolf A and Stammler G (2015) Binding of the respiratory chain inhibitor ametoctradin to the mitochondrial bc1 complex. Pest Manag Sci 72, 591-602.
Zhou Y, Chen L, Hu J, Duan H, Lin D, Liu P, Meng Q, Li B, Si N, Liu C et al. (2015) Resistance mechanisms and molecular docking studies of four novel QoI fungicides in Peronophythora litchii. Sci Rep 5, 17466.
Berry EA, Guergova-Kuras M, Huang LS and Crofts AR (2000) Structure and function of cytochrome bc complexes. Annu Rev Biochem 69, 1005-1075.
Crofts AR (2004) The cytochrome bc1 complex: function in the context of structure. Annu Rev Physiol 66, 689-733.
Xia D, Esser L, Tang W-K, Zhou F, Zhou Y, Yu L and Yu C-A (2013) Structural analysis of cytochrome bc1 complexes: implications to the mechanism of function. Biochim Biophys Acta 1827, 1278-1294.
Trumpower BL (1990) The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J Biol Chem 265, 11409-11412.
Zhang H, Chobot SE, Osyczka A, Wraight CA, Dutton PL and Moser CC (2008) Quinone and non-quinone redox couples in complex III. J Bioenerg Biomembr 40, 493-499.
Mitchell P (1975) Protonmotive Q-cycle - general formulation. FEBS Lett 59, 137-139.
Crofts AR, Shinkarev VP, Kolling DRJ and Hong S (2003) The modified Q-cycle explains the apparent mismatch between the kinetics of reduction of cytochromes c1 and bH in the bc1 complex. J Biol Chem 278, 36191-36201.
Osyczka A, Moser CC and Dutton PL (2005) Fixing the Q cycle. Trends Biochem Sci 30, 176-182.
Cape JL, Bowman MK and Kramer DM (2006) Understanding the cytochrome bc complexes by what they don't do. The Q-cycle at 30. Trends Plant Sci 11, 46-55.
Crofts AR, Holland JT, Victoria D, Kolling DRJ, Dikanov SA, Gilbreth R, Lhee S, Kuras R and Kuras MG (2008) The Q-cycle reviewed: how well does a monomeric mechanism of the bc1 complex account for the function of a dimeric complex? Biochim Biophys Acta 1777, 1001-1019.
Swierczek M, Cieluch E, Sarewicz M, Borek A, Moser CC, Dutton PL and Osyczka A (2010) An electronic bus bar lies in the core of cytochrome bc1. Science 329, 451-454.
Crofts AR, Guergova-Kuras M, Huang L, Kuras R, Zhang Z and Berry EA (1999) Mechanism of ubiquinol oxidation by the bc1 complex: role of the iron sulfur protein and its mobility. Biochemistry 38, 15791-15806.
Darrouzet E and Daldal F (2002) Movement of the iron-sulfur subunit beyond the ef loop of cytochrome b is required for multiple turnovers of the bc1 complex but not for single turnover Qo site catalysis. J Biol Chem 277, 3471-3476.
Darrouzet E and Daldal F (2003) Protein-protein interactions between cytochrome b and the Fe-S protein subunits during QH2 oxidation and large-scale domain movement in the bc1 complex. Biochemistry 42, 1499-1507.
Crofts AR, Hong S, Wilson C, Burton R, Victoria D, Harrison C and Schulten K (2013) The mechanism of ubihydroquinone oxidation at the Qo-site of the cytochrome bc1 complex. Biochim Biophys Acta 1827, 1362-1377.
Crofts AR, Lhee S, Crofts SB, Cheng J and Rose S (2006) Proton pumping in the bc1 complex: a new gating mechanism that prevents short circuits. Biochim Biophys Acta 1757, 1019-1034.
Rutherford AW, Osyczka A and Rappaport F (2012) Back-reactions, short-circuits, leaks and other energy wasteful reactions in biological electron transfer: redox tuning to survive life in O2. FEBS Lett 586, 603-616.
Pietras R, Sarewicz M and Osyczka A (2016) Distinct properties of semiquinone species detected at the ubiquinol oxidation Qo site of cytochrome bc1 and their mechanistic implications. J Roy Soc Interface 13, 20160133.
Fisher N, Bowman M and Kramer DM (2016) Electron transfer reactions at the Qo site of the cytochrome bc1 complex: the good, the bad, and the ugly. In Cytochrome Complexes Evolution Structures, Energy Transduction, Signaling (Cramer WA and Kallas T, eds), pp. 419-434. Springer Netherlands, Dordrecht.
Amporndanai K, Johnson RM, O'Neill PM, Fishwick CWG, Jamson AH, Rawson S, Muench SP, Hasnain SS and Antonyuk SV (2018) X-ray and cryo-em structures of inhibitor-bound cytochrome bc1 complexes for structure-based drug discovery. IUCrJ 5, 200-210.
Fisher N, Brown AC, Sexton G, Cook A, Windass J and Meunier B (2004) Modeling the Qo site of crop pathogens in Saccharomyces cerevisiae cytochrome b. Eur J Biochem 271, 2264-2271.
Fisher N and Meunier B (2005) Re-examination of inhibitor resistance conferred by qo-site mutations in cytochrome b using yeast as a model system. Pest Manag Sci 61, 973-978.
Vallières C, Fisher N, Antoine T, Al-Helal M, Stocks P, Berry NG, Lawrenson AS, Ward SA, O'Neill PM, Biagini GA et al. (2012) HDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complex. Antimicrob Agent Chemother 56, 3739-3747.
Dreinert A, Wolf A, Mentzel T, Meunier B and Fehr M (2018) The cytochrome bc1 complex inhibitor ametoctradin has an unusual binding mode. Biochim Biophys Acta 1859, 567-576.
Song Z, Iorga BI, Mounkoro P, Fisher N and Meunier B (2018) The antimalarial compound ELQ-400 is an unusual inhibitor of the bc1 complex, targeting both Qo and Qi sites. FEBS Lett 62, 327-411.
Crofts AR, Barquera B, Gennis RB, Kuras R, Guergova-Kuras M and Berry EA (1999) Mechanism of ubiquinol oxidation by the bc1 complex: different domains of the quinol binding pocket and their role in the mechanism and binding of inhibitors. Biochemistry 38, 15807-15826.
Esser L, Quinn B, Li Y-F, Zhang M, Elberry M, Yu L, Yu C-A and Xia D (2004) Crystallographic studies of quinol oxidation site inhibitors: a modified classification of inhibitors for the cytochrome bc1 complex. J Mol Biol 341, 281-302.
Gao X, Wen X, ChangAn Y, Esser L, Tsao S, Quinn B, Zhang L, Linda Y and Xia D (2002) The crystal structure of mitochondrial cytochrome bc1 in complex with famoxadone: the role of aromatic-aromatic interaction in inhibition. Biochemistry 41, 11692-11702.
Palsdottir H, Lojero CG, Trumpower BL and Hunte C (2003) Structure of the yeast cytochrome bc1 complex with a hydroxyquinone anion Qo site inhibitor bound. J Biol Chem 278, 31303-31311.
von Jagow G and Link TA (1986) Use of specific inhibitors on the mitochondrial bc1 complex. Methods Enzymol 126, 253-271.
Berry EA, Huang LS, Zhang Z and Kim SH (1999) Structure of the avian mitochondrial cytochrome bc1 complex. J Bioenerg Biomembr 31, 177-190.
Hunte C, Koepke J, Lange C, Rossmanith T and Michel H (2000) Structure at 2.3Å resolution of the cytochrome bc1 complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. Structure 8, 669-684.
Gao X, Wen X, Esser L, Quinn B, Yu L, Yu C-A and Xia D (2003) Structural basis for the quinone reduction in the bc1 complex: a comparative analysis of crystal structures of mitochondrial cytochrome bc1 with bound substrate and inhibitors at the Qi site. Biochemistry 42, 9067-9080.
Huang L-S, Cobessi D, Tung EY and Berry EA (2005) Binding of the respiratory chain inhibitor antimycin to the mitochondrial bc1 complex: a new crystal structure reveals an altered intramolecular hydrogen-bonding pattern. J Mol Biol 351, 573-597.
Zhang Z, Huang L, Shulmeister VM, Chi Y-I, Kim KK, Hung L-W, Crofts AR, Berry EA and Kim S-H (1998) Electron transfer by domain movement in cytochrome bc1. Nature 392, 677-684.
Berry EA, Huang L-S, Lee D-W, Daldal F, Nagai K and Minagawa N (2010) Ascochlorin is a novel, specific inhibitor of the mitochondrial cytochrome bc1 complex. Biochim Biophys Acta 1797, 360-370.
Boveris A, Cadenas E and Stoppani AO (1976) Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J 156, 435-444.
Sun J and Trumpower BL (2003) Superoxide anion generation by the cytochrome bc1 complex. Arch Biochem Biophys 419, 198-206.
Dröse S and Brandt U (2008) The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J Biol Chem 283, 21649-21654.
Muller FL, Roberts AG, Bowman MK and Kramer DM (2003) Architecture of the Qo site of the cytochrome bc1 complex probed by superoxide production. Biochemistry 42, 6493-6499.
Fisher N, Majid RA, Antoine T, Al-Helal M, Warman AJ, Johnson DJ, Lawrenson AS, Ranson H, O'Neill PM, Ward SA et al. (2012) Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression. J Biol Chem 287, 9731-9741.
von Jagow G, Ljungdahl PO, Graf P, Ohnishi T and Trumpower BL (1984) An inhibitor of mitochondrial respiration which binds to cytochrome b and displaces quinone from the iron-sulfur protein of the cytochrome bc1 complex. J Biol Chem 259, 6318-6326.
Brandt U, Schägger H and von Jagow G (1988) Characterisation of binding of the methoxyacrylate inhibitors to mitochondrial cytochrome c reductase. Eur J Biochem 173, 499-506.
Mounkoro P, Michel T, Benhachemi R, Surpateanu G, Iorga BI, Fisher N and Meunier B (2018) Mitochondrial complex III Qi-site inhibitor resistance mutations found in laboratory selected mutants and field isolates. Pest Manag Sci 75, 2107-2114.
Torriani SFF, Melichar JPE, Mills C, Pain N, Sierotzki H and Courbot M (2015) Zymoseptoria tritici: a major threat to wheat production, integrated approaches to control. Fungal Genet Biol 79, 8-12.
Bartlett DW, Clough JM, Godwin JR, Hall AA, Hamer M and Parr-Dobrzanski B (2002) The strobilurin fungicides. Pest Manag Sci 58, 649-662.
Sierotzki H, Wullschleger J and Gisi U (2000) Point mutation in cytochrome b gene conferring resistance to strobilurin fungicides in Erysiphe graminis f. Sp. Tritici field isolates. Pestic Biochem Physiol 68, 107-112.
Heaney S, Hall A, Davis S and Olaya G (2000) Resistance to fungicides in the QoI-STAR cross resistance group: current perspectives. In Brighton Crop Protection Conference-Pests and Diseases (Brighton, UK), pp. 755-762.
Kraiczy P, Haase U, Gencic S, Flindt S, Anke T, Brandt U and von Jagow G (1996) The molecular basis for the natural resistance of the cytochrome bc1 complex from strobilurin-producing Basidiomycetes to center Qp inhibitors. Eur J Biochem 235, 54-63.
Grasso V, Palermo S, Sierotzki H, Garibaldi A and Gisi U (2006) Cytochrome b gene structure and consequences for resistance to Qo inhibitor fungicides in plant pathogens. Pest Manag Sci 62, 465-472.
Vallières C, Trouillard M, Dujardin G and Meunier B (2011) Deleterious effect of the Qo inhibitor compound resistance-conferring mutation G143A in the intron-containing cytochrome b gene and mechanisms for bypassing it. Appl Environ Microbiol 77, 2088-2093.
Sierotzki H, Frey R, Wullschleger J, Palermo S, Karlin S, Godwin J and Gisi U (2007) Cytochrome b gene sequence and structure of Pyrenophora teres and P. tritici-repentis and implications for QoI resistance. Pest Manag Sci 63, 225-233.
Standish JR, Brenneman TB and Stevenson KL (2019) Quantifying the effects of a G137S substitution in the cytochrome bc1 of venturia effusa on azoxystrobin sensitivity using a detached leaf assay. Plant Dis 103, 841-845.
Song Z, Lalève A, Vallières C, McGeehan JE, Lloyd RE and Meunier B (2016) Human mitochondrial cytochrome b variants studied in yeast: not all are silent polymorphisms. Hum Mutat 37, 933-941.
Wenz T, Covian R, Hellwig P, MacMillan F, Meunier B, Trumpower BL and Hunte C (2007) Mutational analysis of cytochrome b at the ubiquinol oxidation site of yeast complex III. J Biol Chem 282, 3977-3988.
Suemoto H, Matsuzaki Y and Iwahashi F (2019) Metyltetraprole, a novel putative complex III inhibitor, targets known QoI-resistant strains of Zymoseptoria tritici and Pyrenophora teres. Pest Manag Sci 75, 1181-1189.
Arakawa A, Kasai Y, Yamazaki K and Iwahashi F (2018) Features of interactions responsible for antifungal activity against resistant type cytochrome bc1: a data-driven analysis based on the binding free energy at the atomic level. PLoS One 13, e0207673-16.
Fontaine S, Remuson F, Caddoux L and Barrès B (2019) Investigation of the sensitivity of Plasmopara viticola to amisulbrom and ametoctradin in French vineyards using bioassays and molecular tools. Pest Manag Sci 50, 3-9.
Cherrad S, Hernandes C, Steva H and Vacher S (2018) Resistance de Plasmopara viticola aux inhibiteurs du complexe III : un point sur la caracterisation phenotypique et genotypique des souches. In 12th International Conference on Plant Diseases, (Tours, France), pp. 449-459.
Usuki Y, Tani K, Fujita K and Taniguchi M (2001) Uk-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. VI(1). Structure-activity relationships of UK-2A. J Antibiot 54, 600-602.
Owen WJ, Yao C, Myung K, Kemmitt G, Leader A, Meyer KG, Bowling AJ, Slanec T and Kramer VJ (2017) Biological characterization of fenpicoxamid, a new fungicide with utility in cereals and other crops. Pest Manag Sci 73, 2005-2016.
Young DH, Wang NX, Meyer ST and Avila-Adame C (2017) Characterization of the mechanism of action of the fungicide fenpicoxamid and its metabolite UK-2A. Pest Manag Sci 74, 489-498.
Wood PM and Hollomon DW (2003) A critical evaluation of the role of alternative oxidase in the performance of strobilurin and related fungicides acting at the Qo site of complex III. Pest Manag Sci 59, 499-511.
Lucas JA, Hawkins NJ and Fraaije BA (2015) The evolution of fungicide resistance. Adv Appl Microbiol 90, 29-92.
Omrane S, Audéon C, Ignace A, Duplaix C, Aouini L, Kema G, Walker A-S and Fillinger S (2017) Plasticity of the MFS1 promoter leads to multidrug resistance in the wheat pathogen Zymoseptoria tritici. mSphere 2, 3-19.
Omrane S, Sghyer H, Audéon C, Lanen C, Duplaix C, Walker A-S and Fillinger S (2015) Fungicide efflux and the mgmfs1 transporter contribute to the multidrug resistance phenotype in Zymoseptoria tritici field isolates. Environ Microbiol 17, 2805-2823.
Moore AL, Shiba T, Young L, Harada S, Kita K and Ito K (2013) Unraveling the heater: new insights into the structure of the alternative oxidase. Annu Rev Plant Biol 64, 637-663.
Young L, May B, Shiba T, Harada S, Inaoka DK, Kita K and Moore AL (2016) Structure and mechanism of action of the alternative quinol oxidases. In Cytochrome Complexes Evolution Structures, Energy Transduction, Signaling (Cramer WA and Kallas T, eds), pp. 375-394. Springer Netherlands, Dordrecht.
Hayward JA and van Dooren GG (2019) Same same, but different: Uncovering unique features of the mitochondrial respiratory chain of apicomplexans. Mol Biochem Parasit 232, 111204-111208.
Ziogas BN, Baldwin BC and Young JE (1997) Alternative respiration: a biochemical mechanism of resistance to azoxystrobin (ICIA 5504) in Septoria tritici. Pestic Sci 50, 28-34.
Yukioka H, Inagaki S, Tanaka R, Katoh K, Miki N, Mizutani A and Masuko M (1998) Transcriptional activation of the alternative oxidase gene of the fungus Magnaporthe grisea by a respiratory-inhibiting fungicide and hydrogen peroxide. Biochim Biophs Acta 1442, 161-169.
Sierotzki H, Parisi S, Steinfeld U, Tenzer I, Poirey S and Gisi U (2000) Mode of resistance to respiration inhibitors at the cytochrome bc1 enzyme complex of Mycosphaerella fijiensis field isolates. Pest Manag Sci 56, 833-841.
Miguez M, Reeve C, Wood PM and Hollomon DW (2003) Alternative oxidase reduces the sensitivity of Mycosphaerella graminicola to QoI fungicides. Pest Manag Sci 60, 3-7.
Clarkson AB Jr, Grady RW, Grossman SA, McCallum RJ and Brohn FH (1981) Trypanosoma brucei brucei: a systematic screening for alternatives to the salicylhydroxamic acid-glycerol combination. Mol Biochem Parasitol 3, 271-291.
Liang H-J, Di Y-L, Li J-L, You H and Zhu F-X (2015) Baseline sensitivity of pyraclostrobin and toxicity of SHAM to Sclerotinia sclerotiorum. Plant Dis 99, 267-273.
Giraud E, Ho LHM, Clifton R, Carroll A, Estavillo G, Tan Y-F, Howell KA, Ivanova A, Pogson BJ, Millar AH et al. (2008) The absence of alternative oxidase 1A in Arabidopsis results in acute sensitivity to combined light and drought stress. Plant Physiol 147, 595-610.
Del-Saz NF, Ribas-Carbo M, Mcdonald AE, Lambers H, Fernie AR and Florez-Sarasa I (2018) An in vivo perspective of the role(s) of the alternative oxidase pathway. Trends Plant Sci 23, 206-219.
Kunze B, Höfle G and Reichenbach H (1987) The aurachins, new quinoline antibiotics from myxobacteria: production, physico-chemical and biological properties. J Antibiot 40, 258-265.
Uhrig JF, Jakobs CU, Majewski C and Trebst A (1994) Molecular characterization of two spontaneous antimycin a resistant mutants of Rhodospirillum rubrum. Mol Biochem Parasitol 1187, 347-353.
Hoefnagel MH, Wiskich JT, Madgwick SA, Patterson Z, Oettmeier W and Rich PR (1995) New inhibitors of the ubiquinol oxidase of higher plant mitochondria. Eur J Biochem 233, 531-537.
Ebiloma GU, Balogun EO, Cueto-Díaz EJ, de Koning HP and Dardonville C (2019) Alternative oxidase inhibitors: mitochondrion-targeting as a strategy for new drugs against pathogenic parasites and fungi. Med Res Rev 39, 1553-1602.
Fujii K and Takakura S (1998) Pyricut (difulmetorim, UBF-002EC): a new fungicide for ornamental use. Agrochem Japan 72, 14-16.
Mizutani A, Miki N, Yukioka H, Tamura H and Masuko MP (1996) A possible mechanism of control of rice blast disease by a novel alkoxyiminoacetamide fungicide, SSF126. Phytopathology 86, 295-300.
Minagawa N, Koga S, Nakano M, Sakajo S and Yoshimoto A (1992) Possible involvement of superoxide anion in the induction of cyanide-resistant respiration in Hansenula anomala. FEBS Lett 302, 217-219.
Eprintsev AT, Mal'tseva EV, Shatskikh AS and Popov VN (2011) Involvement of hydrogen peroxide in the regulation of coexpression of alternative oxidase and rotenone-insensitive NADH dehydrogenase in tomato leaves and calluses. Biol Bull 38, 36-41.
Zuccolo M, Kunova A, Musso L, Forlani F, Pinto A, Vistoli G, Gervasoni S, Cortesi P and Dallavalle S (2019) Dual-active antifungal agents containing strobilurin and SDHI-based pharmacophores. Sci Rep 9, 11377-11412.
Biagini GA, Fisher N, Berry N, Stocks PA, Meunier B, Williams DP, Bonar-Law R, Bray PG, Owen A, O'Neill PM et al. (2008) Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex. Mol Pharmacol 73, 1347-1355.
Nixon GL, Pidathala C, Shone AE, Antoine T, Fisher N, O'Neill PM, Ward SA and Biagini GA (2013) Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era. Future Med Chem 5, 1573-1591.
Srivastava IK, Rottenberg H and Vaidya AB (1997) Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J Biol Chem 272, 3961-3966.
Biagini GA, Viriyavejakul P, O'Neill PM, Bray PG and Ward SA (2006) Functional characterization and target validation of alternative complex I of Plasmodium falciparum mitochondria. Antimicrob Agent Chemother 50, 1841-1851.
Antoine T, Fisher N, Amewu R, O'Neill PM, Ward SA and Biagini GA (2014) Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential. J Antimicrob Chemother 69, 1005-1016.
Hammond DJ, Burchell JR and Pudney M (1985) Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro. Mol Biochem Parasitol 14, 97-109.
Seymour KK, Yeo AE, Rieckmann KH and Christopherson RI (1997) DCTP levels are maintained in Plasmodium falciparum subjected to pyrimidine deficiency or excess. Ann Trop Med Parasitol 91, 603-609.
Allman EL, Painter HJ, Samra J, Carrasquilla M and Llinas M (2016) Metabolomic profiling of the malaria box reveals antimalarial target pathways. Antimicrob Agents Chemother 60, 6635-6649.
Painter HJ, Morrisey JM, Mather MW and Vaidya AB (2007) Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum. Nature 446, 88-91.
Bulusu V, Jayaraman V and Balaram H (2011) Metabolic fate of fumarate, a side product of the purine salvage pathway in the intraerythrocytic stages of Plasmodium falciparum. J Biol Chem 286, 9236-9245.
White NJ (1997) Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agent Chemother 41, 1413-1422.
McCarthy JS, Sekuloski S, Griffin PM, Elliott S, Douglas N, Peatey C, Rockett R, O'Rourke P, Marquart L, Hermsen C et al. (2011) A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS One 6, e21914.
Collins KA, Rückle T, Elliott S, Marquart L, Ballard E, Chalon S, Griffin P, Möhrle JJ and McCarthy JS (2019) DSM265 at 400 milligrams clears asexual stage parasites but not mature gametocytes from the blood of healthy subjects experimentally infected with Plasmodium falciparum. Antimicrob Agents Chemother 63, e01837-18.
McCarthy JS, Lotharius J, Rückle T, Chalon S, Phillips MA, Elliott S, Sekuloski S, Griffin P, Ng CL, Fidock DA et al. (2017) Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1A/1B randomised study. Lancet Infect Dis 17, 626-635.
Lalloo DG and Hill DR (2008) Preventing malaria in travellers. BMJ 336, 1362-1366.
Dembele L, Gego A, Zeeman A-M, Franetich J-F, Silvie O, Rametti A, Le Grand R, Dereuddre-Bosquet N, Sauerwein R, van Gemert G-J et al. (2011) Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS One 6, e18162.
Nixon GL, Moss DM, Shone AE, Lalloo DG, Fisher N, O'Neill PM, Ward SA and Biagini GA (2013) Antimalarial pharmacology and therapeutics of atovaquone. J Antimicrob Chemother 68, 977-985.
Osei-Akoto A, Orton LC and Owusu-Ofori S (2009) Atovaquone-proguanil for treating uncomplicated malaria. Cochrane Database Syst Rev 2005, CD004529.
LaRocque RC, Rao SR, Lee J, Ansdell V, Yates JA, Schwartz BS, Knouse M, Cahill J, Hagmann S, Vinetz J et al. (2012) Global travepinet: a national consortium of clinics providing care to international travelers-analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk us international travelers, 2009-2011. Clin Infect Dis 54, 455-462.
Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K and Cheng Q (2000) Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother 44, 2100-2108.
Fivelman QL, Butcher GA, Adagu IS, Warhurst DC and Pasvol G (2002) Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malar J 1, 1.
Schwartz E, Bujanover S and Kain KC (2003) Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa. Clin Infect Dis 37, 450-451.
Musset L, Bouchaud O, Matheron S, Massias L and Le Bras J (2006) Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. Microbes Infect 8, 2599-2604.
Berry A, Senescau A, Lelievre J, Benoit-Vical F, Fabre R, Marchou B and Magnaval JF (2006) Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance. Trans R Soc Trop Med Hyg 100, 986-988.
Chiodini PL, Conlon CP, Hutchinson DB, Farquhar JA, Hall AP, Peto TE, Birley H and Warrell DA (1995) Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria. J Antimicrob Chemother 36, 1073-1078.
Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB and Canfield CJ (1996) Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 54, 62-66.
Vaidya AB and Arasu P (1987) Tandemly arranged gene clusters of malarial parasites that are highly conserved and transcribed. Mol Biochem Parasitol 22, 249-257.
Goodman CD, Siregar JE, Mollard V, Vega-Rodriguez J, Syafruddin D, Matsuoka H, Matsuzaki M, Toyama T, Sturm A, Cozijnsen A et al. (2016) Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes. Science 352, 349-353.
Bakshi RP, Tatham LM, Savage AC, Tripathi AK, Mlambo G, Ippolito MM, Nenortas E, Rannard SP, Owen A and Shapiro TA (2018) Long-acting injectable atovaquone nanomedicines for malaria prophylaxis. Nat Commun 9, 315.
Xiang H, McSurdy-Freed J, Moorthy GS, Hugger E, Bambal R, Han C, Ferrer S, Gargallo D and Davis CB (2006) Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitor. J Pharm Sci 95, 2657-2672.
Yeates CL, Batchelor JF, Capon EC, Cheesman NJ, Fry M, Hudson AT, Pudney M, Trimming H, Woolven J, Bueno JM et al. (2008) Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials. J Med Chem 51, 2845-2852.
Bueno JM, Manzano P, García MC, Chicharro J, Puente M, Lorenzo M, García A, Ferrer S, Gómez RM, Fraile MT et al. (2011) Potent antimalarial 4-pyridones with improved physico-chemical properties. Bioorg Med Chem Lett 21, 5214-5218.
Wernsdorfer WH and Payne D (1991) The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther 50, 95-121.
Winter RW, Kelly JX, Smilkstein MJ, Dodean R, Bagby GC, Rathbun RK, Levin JI, Hinrichs D and Riscoe MK (2006) Evaluation and lead optimization of anti-malarial acridones. Exp Parasitol 114, 47-56.
Chou AC and Fitch CD (1993) Control of heme polymerase by chloroquine and other quinoline derivatives. Biochem Biophys Res Commun 195, 422-427.
Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL and Ridley RG (1998) An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem Pharmacol 55, 727-736.
Dorn A, Scovill JP, Ellis WY, Matile H, Ridley RG and Vennerstrom JL (2001) Short report: floxacrine analog WR 243251 inhibits hematin polymerization. Am J Trop Med Hyg 65, 19-20.
Auparakkitanon S, Noonpakdee W, Ralph RK, Denny WA and Wilairat P (2003) Antimalarial 9-anilinoacridine compounds directed at hematin. Antimicrob Agents Chemother 47, 3708-3712.
Auparakkitanon S, Chapoomram S, Kuaha K, Chirachariyavej T and Wilairat P (2006) Targeting of hematin by the antimalarial pyronaridine. Antimicrob Agents Chemother 50, 2197-2200.
Suswam E, Kyle D and Lang-Unnasch N (2001) Plasmodium falciparum: the effects of atovaquone resistance on respiration. Exp Parasitol 98, 180-187.
Stocks PA, Barton V, Antoine T, Biagini GA, Ward SA and O'Neill PM (2014) Novel inhibitors of the Plasmodium falciparum electron transport chain. Parasitology 141, 50-65.
Winter RW, Kelly JX, Smilkstein MJ, Dodean R, Hinrichs D and Riscoe MK (2008) Antimalarial quinolones: synthesis, potency, and mechanistic studies. Exp Parasitol 118, 487-497.
Nilsen A, LaCrue AN, White KL, Forquer IP, Cross RM, Marfurt J, Mather MW, Delves MJ, Shackleford DM, Saenz FE et al. (2013) Quinolone- 3-diarylethers: a new class of antimalarial drug. Sci Transl Med 5, 177ra37.
Salzer W, Timmler H and Andersag H (1948) Über einen neuen, gegen vogelmalaria wirksamen verbindungstypus. Chem Ber 81, 12-19.
Fang J and Beattie DS (2003) External alternative NADH dehydrogenase of Saccharomyces cerevisiae: a potential source of superoxide. Free Radic Biol Med 34, 478-488.
Lane KD, Mu J, Lu J, Windle ST, Liu A, Sun PD and Wellems TE (2018) Selection of Plasmodium falciparum cytochrome B mutants by putative PfNDH2 inhibitors. Proc Natl Acad Sci USA 115, 6288-6290.
Frueh L, Li Y, Mather MW, Li Q, Pou S, Nilsen A, Winter RW, Forquer IP, Pershing AM, Xie LH et al. (2017) Alkoxycarbonate ester prodrugs of preclinical drug candidate ELQ-300 for prophylaxis and treatment of malaria. ACS Infect Dis 3, 728-735.
Smilkstein MJ, Pou S, Krollenbrock A, Bleyle LA, Dodean RA, Frueh L, Hinrichs DJ, Li Y, Martinson T, Munar MY et al. (2019) ELQ-331 as a prototype for extremely durable chemoprotection against malaria. Malar J 18, 291.
da Cruz FP, Martin C, Buchholz K, Lafuente-Monasterio MJ, Rodrigues T, Sönnichsen B, Moreira R, Gamo F-J, Marti M, Mota MM et al. (2012) Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug. J Infect Dis 205, 1278-1286.
Cowley R, Leung SC, Fisher N, Al-Helal M, Berry NG, Lawrenson AS, Sharma R, Shone AE, Ward SA, Biagini GA et al. (2012) The development of quinolone esters as novel antimalarial agents targeting the Plasmodium falciparum bc1 protein complex. Med Chem Comm 3, 39.
Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J et al. (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7, 539-545.
Sobolev V, Sorokine A, Prilusky J, Abola EE and Edelman M (1999) Automated analysis of interatomic contacts in proteins. Bioinformatics 15, 327-332.